Breaking News

Almac Opens Additional Companion Diagnostic Lab in NC

March 8, 2016

Will provide a U.S. base to support CDx development partnerships

Almac Group’s Diagnostics Business Unit has opened its new companion diagnostic development facility in the Research Triangle Park region of NC. This facility will provide a U.S. base to support Almac’s CDx development partnerships, as well as a CLIA-accredited lab to support the downstream delivery of assays for patient testing.  
 
The custom designed facility is equipped with microarray and qPCR platforms appropriate for companion diagnostic development and will operate both research-use-only and clinical diagnostic tests. Plans are also in place to add additional technology platforms including NGS in the coming year.
 
“The opening of our new CDx facility in the U.S. is Almac Diagnostics’ latest initiative to better serve our global Biopharma partners. As we experience increased client demand for our companion diagnostic development services, this latest expansion will significantly enhance Almac’s offering, increasing capacity and further demonstrating our commitment to personalised healthcare,” said Professor Paul Harkin, president and managing director of Almac Diagnostics.
blog comments powered by Disqus
  • FDA & Drug Development

    FDA & Drug Development

    Rachelle Du2019Souza, Regulatory Heights Inc.||September 8, 2016
    You must perform the necessary due diligence to stay on top of regulatory developments

  • The Role of Alliances in Modern Drug Development

    The Role of Alliances in Modern Drug Development

    Dr. Claire Madden-Smith, Senior Vice President, Juniper Pharma Services||September 8, 2016
    Combining expertise to get drug candidates through development

  • Successful Method Transfer of Solid Oral Dosage

    Successful Method Transfer of Solid Oral Dosage

    John Frankonis, Ropack Pharma Solutions||June 2, 2016
    The three steps outlined will help guide the process of completing a successful analytical method transfer